TAVI: Direct Flow to put its valve up against Medtronic's CoreValve
The FDA says Direct Flow Medical can compare its transcatheter aortic valve implant with Medtronic's CoreValve in a clinical trial that's now slated to include a high-risk cohort.
Direct Flow Medical Inc., Food & Drug Administration (FDA), MedtronicNews Well, Clinical Trials, Replacement Heart Valves, TAVIread more
Source: Mass Device - Category: Medical Equipment Authors: Brad Perriello Source Type: news
More News: Cardiology | Clinical Trials | Heart | Heart Valve Disease | Heart Valve Surgery | Heart Valves | Medical Devices